All Pharma articles – Page 7
-
NewsNHS use of e-prescribing can be a ‘risk to patient safety’
Poorly-implemented electronic prescribing systems in NHS hospitals are putting patients’ lives at risk, the NHS’s safety watchdog has warned.
-
Expert BriefingAbout that bus…?: What the Boris deal means for the NHS: a bitesize guide
Welcome to the ‘About that bus…?’ weekly newsletter – giving you the inside track on how the fallout from Brexit is affecting the NHS at national and local level, edited by James Illman. Contact me in confidence.
-
NewsNHS England finally strikes deal for high value drug
A deal has been struck to make a life-extending cystic fibrosis drug available on the NHS for the first time.
-
NewsNew Brexit plan worse for NHS than May’s deal, experts warn
The NHS will be exposed to more risk by the government’s latest Brexit deal than by Theresa May’s original agreement, health service experts and lobby groups have told HSJ.
-
Expert BriefingFollowing the Money: At last, the ‘truth’ about NHS privatisation
HSJ’s expert briefing on NHS finances, savings and efforts to get the health service back in the black. This week by HSJ editor Alastair McLellan.
-
Expert Briefing‘About that bus…?’: In short supply this winter
Welcome to the ‘About that bus…?’ weekly newsletter – giving you the inside track on how the fallout from Brexit is affecting the NHS at national and local level, edited by James Illman. Contact me in confidence.
-
NewsMinisters confirm ban on some drug exports ahead of Brexit deadline
Ministers have confirmed plans for a ban on the export of certain medicines, starting with a group of 24 drugs including 19 hormone replacement therapy treatments, ahead of the no-deal Brexit deadline at the end of this month.
-
Expert Briefing‘About that bus…?’: Ministers’ tactics to see off threat of a Brexit drugs sell-off revealed
Welcome to the ‘About that bus…?’ weekly newsletter – giving you the inside track on how the fallout from Brexit is affecting the NHS at national and local level, edited by James Illman. Contact me in confidence.
-
CommentThe dangers of Labour's attempt to cut drug costs
The Labour party’s proposals aimed at drug costs are radical but risky, writes Tony Hockley
-
NewsCorbyn vows to create state-run drug company and seize patent rights
Jeremy Corbyn says a Labour government would create a state-run pharmaceutical company to make generic versions of drugs the NHS cannot afford.
-
Expert Briefing‘About that bus…?’: The NHS’ biggest no-deal Brexit threat
Welcome to the ‘About that bus…?’ weekly newsletter – giving you the inside track on how the fallout from Brexit is affecting the NHS at national and local level, edited by James Illman Contact me in confidence.
-
NewsExclusive: NHS chiefs want latest no-deal plans from government
NHS chiefs have urged ministers to publish their up-to-date plans for a no-deal Brexit, in the wake of the release of Project Yellowhammer documents.
-
Comment‘Mini-deal’ agreements needed to keep both UK and EU patients safe
Layla McCay on concerns that a no-deal Brexit will affect healthcare
-
Expert Briefing‘About that bus…’: Preparing for ‘Armageddon’ and intense political scrutiny
Welcome to the ‘About that bus…’ weekly newsletter: giving you the inside track on how the fallout from Brexit is affecting the NHS at national and local level, edited by James Illman Contact me in confidence.
-
NewsFears no-deal Brexit’s drugs stockpile could be sold off
Fresh concerns have been raised that drugs stockpiled for a no-deal Brexit could be sold off before the 31 October deadline unless ministers intervene.
-
NewsNHS faces legal action from ‘abandoned’ IV feed patients
The NHS and the national medical regulator could face legal action over the shortage of intravenous feed supplies for hundreds of UK patients, HSJ has learned.
-
NewsRegulator announces interim CEO
The Medicines and Healthcare products Regulatory Agency has appointed an interim chief executive.
-
News‘Smart’ pump overdoses spark national safety probe
A national safety investigation has been launched into the NHS’ use of so-called ‘smart pumps’ after three patients received an overdose of the powerful opioid fentanyl.
-
NewsAndrew Dillon to end his 20 year reign at NICE
Sir Andrew Dillon will step down as the chief executive of the National Institute for Health and Care Excellence in March 2020 after more than 20 years in the role.
-
News‘Reprehensible’ action by regulator sparks call for inquiry
Senior clinicians have called for a review into how hundreds of patients have been left without intravenous food after action by the medical regulator severly curtailed its supply.